{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:56:58Z","timestamp":1791316618018,"version":"4.3.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T00:00:00Z","timestamp":1715385600000},"content-version":"vor","delay-in-days":131,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["E-26\/200.381\/2023"],"award-info":[{"award-number":["E-26\/200.381\/2023"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["308315\/2021-9"],"award-info":[{"award-number":["308315\/2021-9"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"FAPERJ","doi-asserted-by":"publisher","award":["E-26\/201.441\/2021"],"award-info":[{"award-number":["E-26\/201.441\/2021"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"FAPERJ","doi-asserted-by":"publisher","award":["E-26\/205.879\/2022"],"award-info":[{"award-number":["E-26\/205.879\/2022"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Research in Microbial Sciences"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/j.crmicr.2024.100242","type":"journal-article","created":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T22:22:21Z","timestamp":1715725341000},"page":"100242","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["In vitro antifungal activity of MMV Pathogen Box\u00ae compounds alone or in combination with antifungal drugs against mucormycosis agents"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7378-1990","authenticated-orcid":false,"given":"Fernando","family":"Almeida-Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro Henrique","family":"Ten\u00f3rio-Alvarenga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raiane Valle","family":"da Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rowena Alves","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glauber Ribeiro","family":"de Sousa Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosely Maria","family":"Zancop\u00e9-Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Frases","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Almeida-Paes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.crmicr.2024.100242_bib0001","doi-asserted-by":"crossref","first-page":"249","DOI":"10.14740\/gr1662","article-title":"Gastrointestinal mucormycosis: a clinical review","volume":"16","author":"Addasi","year":"2023","journal-title":"Gastroenterology. Res."},{"key":"10.1016\/j.crmicr.2024.100242_bib0002","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.2217\/fmb-2023-0108","article-title":"Repurposing drugs for fungal infections: advantages and limitations","volume":"18","author":"Almeida-Paes","year":"2023","journal-title":"Future Microbiol."},{"key":"10.1016\/j.crmicr.2024.100242_bib0003","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1128\/AAC.46.11.3591-3596.2002","article-title":"In vitro activity of caspofungin against Candida albicans biofilms","volume":"46","author":"Bachmann","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.crmicr.2024.100242_bib0004","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01230-21","article-title":"Epidemiology and antifungal susceptibilities of Mucoralean fungi in clinical samples from the United States","volume":"59","author":"Badali","year":"2021","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.crmicr.2024.100242_bib0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0240658","article-title":"Identification of two potential inhibitors of Sporothrix brasiliensis and Sporothrix schenckii in the Pathogen Box collection","volume":"15","author":"Borba-Santos","year":"2020","journal-title":"PLoS. One"},{"key":"10.1016\/j.crmicr.2024.100242_bib0006","doi-asserted-by":"crossref","first-page":"e382","DOI":"10.1016\/S2666-5247(21)00326-8","article-title":"Searching for new therapeutic options for the uncommon pathogen Mycobacterium chimaera: an open drug discovery approach","volume":"3","author":"Cantillon","year":"2022","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.crmicr.2024.100242_bib0007","series-title":"Reference method for broth dilution antifungal susceptibility testing of Filamentous fungi","year":"2008"},{"key":"10.1016\/j.crmicr.2024.100242_bib0008","doi-asserted-by":"crossref","DOI":"10.1590\/0074-02760220089","article-title":"New possibilities for chromoblastomycosis and phaeohyphomycosis treatment: identification of two compounds from the MMV Pathogen Box\u00ae that present synergism with itraconazole","volume":"117","author":"Coelho","year":"2022","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.crmicr.2024.100242_bib0009","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229630","article-title":"A screening of the MMV Pathogen Box\u00ae reveals new potential antifungal drugs against the etiologic agents of chromoblastomycosis","volume":"15","author":"Coelho","year":"2020","journal-title":"PLoS. One"},{"key":"10.1016\/j.crmicr.2024.100242_bib0010","doi-asserted-by":"crossref","first-page":"e405","DOI":"10.1016\/S1473-3099(19)30312-3","article-title":"Global guideline for the diagnosis and management of Mucormycosis: an initiative of the European confederation of medical mycology in cooperation with the mycoses study group education and research consortium","volume":"19","author":"Cornely","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.crmicr.2024.100242_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.mmcr.2024.100646","article-title":"Cutaneous mucormycosis with suspected dissemination in a patient with metastatic adrenocortical carcinoma","volume":"44","author":"Dar","year":"2024","journal-title":"Med. Mycol. Case Rep."},{"key":"10.1016\/j.crmicr.2024.100242_bib0012","first-page":"2467","article-title":"Mucormycosis, new causative agents, and new susceptible populations: review of cases in a tertiary care hospital in Iran (2007-2021)","volume":"52","author":"Darazam","year":"2023","journal-title":"Iran J. Public Health"},{"key":"10.1016\/j.crmicr.2024.100242_bib0013","doi-asserted-by":"crossref","first-page":"6574","DOI":"10.3390\/molecules27196574","article-title":"Preliminary structure-activity relationship study of the MMV Pathogen Box compound MMV675968 (2,4-Diaminoquinazoline) unveils novel inhibitors of Trypanosoma brucei brucei","volume":"27","author":"Dize","year":"2022","journal-title":"Molecules."},{"key":"10.1016\/j.crmicr.2024.100242_bib0014","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1099\/jmm.0.000091","article-title":"Differentiation of clinically relevant Mucorales Rhizopus microsporus and R. arrhizus by matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS)","volume":"64","author":"Dolatabadi","year":"2015","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.crmicr.2024.100242_bib0015","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00379-17","article-title":"Screening the Medicines for Malaria Venture Pathogen Box across multiple pathogens reclassifies starting points for open-source drug discovery","volume":"61","author":"Duffy","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.crmicr.2024.100242_bib0016","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41579-022-00720-1","article-title":"Tackling the emerging threat of antifungal resistance to human health","volume":"20","author":"Fisher","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.crmicr.2024.100242_bib0017","doi-asserted-by":"crossref","first-page":"96","DOI":"10.2174\/1874285801105010096","article-title":"Inhibition of growth of highly resistant bacterial and fungal pathogens by a natural product","volume":"5","author":"Hafidh","year":"2011","journal-title":"Open Microbiol. J."},{"key":"10.1016\/j.crmicr.2024.100242_bib0018","doi-asserted-by":"crossref","first-page":"e0912","DOI":"10.1002\/rcr2.912","article-title":"Fatal disseminated mucormycosis associated with COVID-19","volume":"10","author":"Horiguchi","year":"2022","journal-title":"Respirol. Case Rep."},{"key":"10.1016\/j.crmicr.2024.100242_bib0019","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jmii.2022.12.004","article-title":"COVID-19 associated mold infections: review of COVID-19 associated pulmonary aspergillosis and mucormycosis","volume":"56","author":"Huang","year":"2023","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"10.1016\/j.crmicr.2024.100242_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.115010","article-title":"Mucormycosis: a hidden mystery of fungal infection, possible diagnosis, treatment and development of new therapeutic agents","volume":"246","author":"Hussain","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.crmicr.2024.100242_bib0021","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cmi.2018.07.011","article-title":"The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports","volume":"25","author":"Jeong","year":"2019","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.crmicr.2024.100242_bib0022","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1111\/jphp.13273","article-title":"Drug repositioning: a brief overview","volume":"72","author":"Jourdan","year":"2020","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.crmicr.2024.100242_bib0023","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s43441-023-00509-1","article-title":"Factors affecting success of new drug clinical trials","volume":"57","author":"Kim","year":"2023","journal-title":"Ther. Innov. Regul. Sci."},{"key":"10.1016\/j.crmicr.2024.100242_bib0024","doi-asserted-by":"crossref","DOI":"10.1128\/Spectrum.00739-21","article-title":"Identification of small molecule inhibitors of the Pathogen Box against Vibrio cholerae","volume":"9","author":"Kim","year":"2021","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.crmicr.2024.100242_bib0025","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1080\/17460441.2022.2080195","article-title":"Identifying novel drugs with new modes of action for neglected tropical fungal skin diseases (fungal skinNTDs) using an open source drug discovery approach","volume":"17","author":"Lim","year":"2022","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.crmicr.2024.100242_bib0026","doi-asserted-by":"crossref","first-page":"4910","DOI":"10.7150\/thno.56205","article-title":"Drug repurposing for next-generation combination therapies against multidrug-resistant bacteria","volume":"11","author":"Liu","year":"2021","journal-title":"Theranostics."},{"key":"10.1016\/j.crmicr.2024.100242_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2021.111643","article-title":"Mucormycosis: an opportunistic pathogen during COVID-19","volume":"201","author":"Mahalaxmi","year":"2021","journal-title":"Environ. Res."},{"key":"10.1016\/j.crmicr.2024.100242_bib0028","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ijpddr.2019.06.004","article-title":"Screening the Medicines for Malaria venture pathogen box against piroplasm parasites","volume":"10","author":"Nugraha","year":"2019","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.crmicr.2024.100242_bib0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkg301","article-title":"Synergy, antagonism, and what the chequerboard puts between them","volume":"52","author":"Odds","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"issue":"10","key":"10.1016\/j.crmicr.2024.100242_bib0030","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1021\/acsinfecdis.3c00199","article-title":"Leveraging the MMV Pathogen Box to engineer an antifungal compound with improved efficacy and selectivity against Candida auris","volume":"9","author":"Pan","year":"2023","journal-title":"ACS. Infect. Dis."},{"key":"10.1016\/j.crmicr.2024.100242_bib0031","doi-asserted-by":"crossref","DOI":"10.1007\/s42770-024-01315-z","article-title":"Mucormycosis: a rare disease to notifiable disease","author":"Panda","year":"2024","journal-title":"Braz. J. Microbiol."},{"key":"10.1016\/j.crmicr.2024.100242_bib0032","doi-asserted-by":"crossref","first-page":"e13016","DOI":"10.1111\/pim.13016","article-title":"COVID-19 associated mucormycosis surge: a review on multi-pathway mechanisms","volume":"46","author":"Pourazizi","year":"2024","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.crmicr.2024.100242_bib0033","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/jof5010026","article-title":"Global epidemiology of mucormycosis","volume":"5","author":"Prakash","year":"2019","journal-title":"J. Fungi."},{"key":"10.1016\/j.crmicr.2024.100242_bib0034","doi-asserted-by":"crossref","first-page":"848","DOI":"10.3390\/jof7100848","article-title":"Changing epidemiology of invasive fungal disease in allogeneic hematopoietic stem cell transplantation","volume":"7","author":"Puerta-Alcalde","year":"2021","journal-title":"J. Fungi."},{"key":"10.1016\/j.crmicr.2024.100242_bib0035","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.cmi.2019.02.018","article-title":"Acquired resistance in fungi: how large is the problem?","volume":"25","author":"Roilides","year":"2019","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.crmicr.2024.100242_bib0036","doi-asserted-by":"crossref","first-page":"ofad704","DOI":"10.1093\/ofid\/ofad704","article-title":"A systematic review of the therapeutic outcome of mucormycosis","volume":"11","author":"Sigera","year":"2023","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.crmicr.2024.100242_bib0037","doi-asserted-by":"crossref","first-page":"5117","DOI":"10.1080\/07391102.2022.2080113","article-title":"Identification and validation of potent inhibitor of Escherichia coli DHFR from MMV pathogen box","volume":"41","author":"Sharma","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.crmicr.2024.100242_bib0038","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s00284-023-03430-w","article-title":"Mucormycosis and its upsurge during COVID-19 epidemic: an updated review","volume":"80","author":"Sharma","year":"2023","journal-title":"Curr. Microbiol."},{"key":"10.1016\/j.crmicr.2024.100242_bib0039","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3390\/jof4030090","volume":"4","author":"Sipsas","year":"2018","journal-title":"Therap. Mucormycosis. J. Fungi"},{"key":"10.1016\/j.crmicr.2024.100242_bib0040","doi-asserted-by":"crossref","first-page":"e10743","DOI":"10.7717\/peerj.10743","article-title":"A novel bicyclic 2,4-diaminopyrimidine inhibitor of Streptococcus suis dihydrofolate reductase","volume":"9","author":"Songsungthong","year":"2021","journal-title":"PeerJ."},{"key":"10.1016\/j.crmicr.2024.100242_bib0041","doi-asserted-by":"crossref","first-page":"15625","DOI":"10.1038\/s41598-019-52176-8","article-title":"Diaminoquinazoline MMV675968 from Pathogen Box inhibits Acinetobacter baumannii growth through targeting of dihydrofolate reductase","volume":"9","author":"Songsungthong","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.crmicr.2024.100242_bib0042","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01640-17","article-title":"Discovery of new inhibitors of Toxoplasma gondii via the Pathogen Box","volume":"62","author":"Spalenka","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.crmicr.2024.100242_bib0043","doi-asserted-by":"crossref","DOI":"10.7573\/dic.2023-7-1","article-title":"Antifungal resistance, combinations and pipeline: oh my!","volume":"12","author":"Stover","year":"2023","journal-title":"Drugs Context."},{"key":"10.1016\/j.crmicr.2024.100242_bib0044","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s40360-021-00538-2","article-title":"In vitro growth inhibitory activity of Medicines for Malaria Venture pathogen box compounds against Leishmania aethiopica","volume":"22","author":"Tadele","year":"2021","journal-title":"BMC Pharmacol. Toxicol."},{"key":"10.1016\/j.crmicr.2024.100242_bib0045","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00253-023-12884-8","article-title":"Old and new strategies in therapy and diagnosis against fungal infections","volume":"108","author":"Vanzolini","year":"2024","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.crmicr.2024.100242_bib0046","doi-asserted-by":"crossref","first-page":"e02006","DOI":"10.1128\/AAC.02006-16","article-title":"Screening the pathogen box for identification of Candida albicans biofilm inhibitors","volume":"61","author":"Vila","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.crmicr.2024.100242_bib0047","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.3201\/eid2907.230524","article-title":"Fatal invasive mold infections after transplantation of organs recovered from drowned donors, United States, 2011-2021","volume":"29","author":"Wu","year":"2023","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.crmicr.2024.100242_bib0048","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3390\/jof9020187","article-title":"Promising antifungal molecules against mucormycosis agents identified from Pandemic response box\u00ae: in vitro and in silico analyses","volume":"9","author":"Xisto","year":"2023","journal-title":"J. Fungi."},{"key":"10.1016\/j.crmicr.2024.100242_bib0049","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/ced.13641","article-title":"Ultrastructural changes of Trichophyton rubrum in tinea unguium after itraconazole therapy in vivo observed using scanning electron microscopy","volume":"43","author":"Yue","year":"2018","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.crmicr.2024.100242_bib0050","doi-asserted-by":"crossref","first-page":"e13674","DOI":"10.1111\/myc.13674","article-title":"Voriconazole plus flucytosine is not superior to amphotericin B deoxycholate plus flucytosine as an induction regimen for cryptococcal meningitis treatment","volume":"67","author":"Zhao","year":"2024","journal-title":"Mycoses."}],"container-title":["Current Research in Microbial Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666517424000245?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666517424000245?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T08:35:31Z","timestamp":1778920531000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666517424000245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":50,"alternative-id":["S2666517424000245"],"URL":"https:\/\/doi.org\/10.1016\/j.crmicr.2024.100242","relation":{},"ISSN":["2666-5174"],"issn-type":[{"value":"2666-5174","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro antifungal activity of MMV Pathogen Box\u00ae compounds alone or in combination with antifungal drugs against mucormycosis agents","name":"articletitle","label":"Article Title"},{"value":"Current Research in Microbial Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crmicr.2024.100242","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100242"}}